Completed PHASE1 INTERVENTIONAL 1-arm NCT01256541

Kristalose as Bowel Evacuant Prior to Colonoscopy

A Single Center, Open-Label, Pilot Study to Determine the Safety, Efficacy, and Patient Preference of Kristalose as a Bowel Evacuant Prior to Colonoscopy

Sponsor: Benaroya Research Institute

Conditions Bowel Evacuant Prior to Colonoscopy

Interventions Kristalose

Updated 6 times since 2017 Last updated: Oct 5, 2011 Started: Dec 31, 2010 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Bowel Evacuant Prior to Colonoscopy and is currently completed. Benaroya Research Institute leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Benaroya Research Institute
Cumberland Pharmaceuticals
Virginia Mason Hospital/Medical Center

Data source: Benaroya Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States